Molecule Holding A/S: Financial statements 2017
CVR: 15511494
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Molecule Holding A/S (CVR 15511494) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK 293,000 compared with DKK 1,186,000 the year before. Equity in the 2017 report amounted to DKK 5,376,000. The solvency ratio was 82.4%.
- Profit/Loss
- DKK 293,000
- Equity
- DKK 5,376,000
- Total Assets
- DKK 6,526,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | 293 t. | 5.4 mio. | - |
| 2016 | - | - | 1.2 mio. | 5.1 mio. | - |
| 2015 | - | -63 t. | 3.3 mio. | 5.6 mio. | - |
| 2014 | - | -69 t. | 1.8 mio. | 3.1 mio. | - |
Official annual report
Keep an eye on Molecule Holding A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Molecule Holding A/S has published its annual report for 2016. The net result was DKK 1,186,000.
About Molecule Holding A/S
Molecule Holding A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 1991. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named MANNOV HOLDING A/S and GCI MANNOV HOLDING A/S. The management consists of Morten Vestergren Frederiksen. The board consists of Steffen Pierini Lüders (chair), Mette Thorn Sørensen and Morten Vestergren Frederiksen. The company is owned by Molecule Holding A/S and WPP Times Square B.V. The company has 0 employees (1999). In 2025, the company reported a gross profit of DKK -237,000 and a net result of DKK 1,045,000 compared with DKK -17,000 the year before. Equity in the 2025 report amounted to DKK 2,427,000.